More Globe Newswire

View Older Stories View Newer Stories

Feb 1, 2024 05:51PM BRBS DEADLINE ALERT: ROSEN, THE FIRST FILING FIRM, Encourages Blue Ridge Bankshares, Inc. Investors to Secure Counsel Before Important February 5 Deadline in Securities Class Action Filed by the Firm
Feb 1, 2024 05:36PM EH DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages EHang Holdings Limited Investors to Secure Counsel Before Important February 2 Deadline in Securities Class Action First Filed by the
Feb 1, 2024 05:30PM Adverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Results on February 8, 2024
Feb 1, 2024 05:30PM BOEING INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Boeing To Contact Him Direct
Feb 1, 2024 05:30PM DRIVEN BRANDS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Driven Brands To Contact H
Feb 1, 2024 05:30PM LOVESAC INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Lovesac To Contact Him Directly T
Feb 1, 2024 05:30PM ESTEE INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Estee To Contact Him Directly To D
Feb 1, 2024 05:30PM GENERAL MOTORS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In General Motors To Contact
Feb 1, 2024 05:30PM ALLOVIR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly T
Feb 1, 2024 05:30PM MERCURY INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Mercury To Contact Him Directly
Feb 1, 2024 05:30PM GRAFTECH INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In GrafTech To Contact Him Directly
Feb 1, 2024 05:30PM CUMMINS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Cummins To Contact Him Directly
Feb 1, 2024 05:30PM EAGLE PHARMACEUTICALS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceutic
Feb 1, 2024 05:28PM Vertex to Announce Fourth Quarter 2023 Financial Results on Thursday, February 29, 2023
Feb 1, 2024 05:15PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cummins Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – CMI
Feb 1, 2024 05:15PM Parks! America Files Preliminary Proxy Statement
Feb 1, 2024 05:15PM Koss Corporation Releases Second Quarter Results
Feb 1, 2024 05:15PM Hammond Power Solutions Announces COO Retirement and Appoints Mr. John Bailey as COO
Feb 1, 2024 05:13PM CORRECTION — NIST Demonstrates Nubeva’s Breakthrough in TLS 1.3 Decryption Technology
Feb 1, 2024 05:08PM PIMCO Closed-End Funds Declare Monthly Common Share Distributions
Feb 1, 2024 05:05PM Minerals Technologies Reports Fourth Quarter 2023 Earnings Per Share of $1.22, or $1.28 Excluding Special Items, a Record for Current Quarter
Feb 1, 2024 05:03PM Ingredion Completes Sale of Business in South Korea
Feb 1, 2024 05:00PM Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 1, 2024 05:00PM The New America High Income Fund, Inc. Declares Dividend
Feb 1, 2024 05:00PM NADP Research Reveals Record in Dental Coverage for Americans
Feb 1, 2024 05:00PM PIEDMONT OFFICE REALTY TRUST DECLARES FIRST QUARTER DIVIDEND
Feb 1, 2024 05:00PM TC Transcontinental Printing to Close its Saint-Hyacinthe Plant
Feb 1, 2024 05:00PM Post Holdings Reports Results for the First Quarter of Fiscal Year 2024; Raises Fiscal Year 2024 Outlook
Feb 1, 2024 05:00PM Baker Hughes Declares Increased Quarterly Dividend
Feb 1, 2024 04:56PM Coin Bureau Unveils Coin Bureau Club, a Premium Membership Offering for Crypto Enthusiasts
Feb 1, 2024 04:46PM Crown Realty Partners Expands Portfolio With Acquisition of Atrium Building in Mississauga
Feb 1, 2024 04:45PM Breakthrough Institute Endorses Bill to Improve Climate Data Coordination at USDA
Feb 1, 2024 04:35PM ARCA biopharma Announces 2023 Financial Results
Feb 1, 2024 04:35PM TriumphPay Announces Addition of Two New Hires to Sales Leadership Team
Feb 1, 2024 04:35PM Advisory: Fortis Inc. to Hold Teleconference and Webcast on February 9 to Discuss 2023 Annual Results
Feb 1, 2024 04:30PM Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024
Feb 1, 2024 04:30PM Arvinas to Present at 6th Annual Guggenheim Biotechnology Conference
Feb 1, 2024 04:30PM Glacier Bancorp Completes Acquisition of Community Financial Group, Inc. in Spokane, Washington
Feb 1, 2024 04:30PM Southside Bancshares, Inc. Increases and Declares Cash Dividend
Feb 1, 2024 04:30PM Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
Feb 1, 2024 04:30PM Guggenheim Investments Announces February 2024 Closed-End Fund Distributions
Feb 1, 2024 04:30PM Travere Therapeutics to Present at the Guggenheim 6th Annual Biotechnology Conference
Feb 1, 2024 04:30PM Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis
Feb 1, 2024 04:30PM Gray and Marquee Broadcasting Swap Television Station Assets
Feb 1, 2024 04:30PM GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 
Feb 1, 2024 04:24PM Stem Holdings, Inc. Announces Effectiveness of Reverse Stock Split on February 1, 2024.
Feb 1, 2024 04:22PM Trian Files Definitive Proxy Statement for Disney’s 2024 Annual Meeting and Recommends “Withhold” on Directors Michael B.G. Froman and Maria Elena Lagomasino
Feb 1, 2024 04:22PM Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering
Feb 1, 2024 04:20PM Enact Completes Forward XOL Reinsurance Transaction as Part of its Diversified Credit Risk Transfer Program
Feb 1, 2024 04:17PM GMAT™ Focus Edition Stands Alone in Business School Assessment as Previous Version Sunsets
View Newer Stories View Older Stories